Biogen (Nasdaq: BIIB) saw its shares fall 8% on Tuesday after a fuller look at mid-stage results for its experimental ...
US AI drug discovery firm Chai Discovery has raised $400 million in a Series C financing, valuing the San Francisco-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results